Predictors of the Therapeutic Efficacy and Consideration of the Best Combination Therapy of Sodium-Glucose Co-transporter 2 Inhibitors

BACKGROUND: We investigated the predictive markers for the therapeutic efficacy and the best combination of sodium-glucose co-transporter 2 (SGLT2) inhibitors (empagliflozin, dapagliflozin, and ipragliflozin) therapy in patients with type 2 diabetes mellitus (T2DM). METHODS: A total of 804 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ji-Yeon, Cho, Yongin, Lee, Minyoung, Kim, You Jin, Lee, Yong-ho, Lee, Byung-Wan, Cha, Bong-Soo, Kang, Eun Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470102/
https://www.ncbi.nlm.nih.gov/pubmed/30688052
http://dx.doi.org/10.4093/dmj.2018.0057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470102/
https://www.ncbi.nlm.nih.gov/pubmed/30688052
http://dx.doi.org/10.4093/dmj.2018.0057

Ejemplares similares